Michael M. Abecassis - Director at PharmaCyte Biotech, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
PMCB on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael M. Abecassis since 11 Mar 2025

Holdings reported by Michael M. Abecassis for PharmaCyte Biotech, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 22,292 $22,737 $1.02 12 Dec 2025 Direct
Common Stock 800 $680 $0.8500 25 Apr 2025 By Transplant Consulting LLC
Stock Option (Right to Buy) 63,233 25 Apr 2025 Direct Common Stock

Transactions reported by Michael M. Abecassis for PharmaCyte Biotech, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.